Plc Glaxosmithkline

Affiliations

  • Director at Decibel Therapeutics Inc. (DBTX), 2021-02-19
  • Large Shareholder at Bicycle Therapeutics Plc (BCYC), 2020-09-18
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2020-07-31
  • Large Shareholder, Director at Pandion Therapeutics Inc. (PAND), 2020-07-22
  • Large Shareholder, Director at Nkarta Inc. (NKTX), 2020-07-17
  • Large Shareholder at Theravance Biopharma Inc. (TBPH), 2020-06-22
  • Director at Turning Point Therapeutics Inc. (TPTX), 2020-05-26
  • Large Shareholder at Progyny Inc. (PGNY), 2020-05-21
  • Large Shareholder, Director at Orchard Therapeutics Plc (ORTX), 2020-01-02
  • Other at Principia Biopharma Inc. (PRNB), 2019-10-22
  • at Fulcrum Therapeutics Inc. (FULC), 2019-07-24
  • Director at Morphic Holding Inc. (MORF), 2019-07-02
  • Other at Chemocentryx Inc. (CCXI), 2018-10-18
  • Other at Liquidia Technologies Inc (LQDA), 2018-08-01
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-18
  • Large Shareholder at Spero Therapeutics Inc. (SPRO), 2018-07-17
  • Large Shareholder at Translate Bio Inc. (TBIO), 2018-07-03
  • Large Shareholder at Aileron Therapeutics Inc (ALRN), 2017-06-28
  • Other at Htg Molecular Diagnostics Inc (HTGM), 2017-03-30
  • Large Shareholder at Crispr Therapeutics Ag (CRSP), 2016-10-26
  • Large Shareholder at Theravance Inc (THRX), 2015-08-07
  • Other at Applied Genetic Technologies Corp (AGTC), 2015-02-24
  • Other at Amicus Therapeutics Inc (FOLD), 2014-10-28
  • Other at Nupathe Inc. (PATH), 2014-02-24
  • Other at Concert Pharmaceuticals Inc. (CNCE), 2014-02-20
  • Large Shareholder at Oncomed Pharmaceuticals Inc (OMED), 2013-07-23
  • Large Shareholder at Response Genetics Inc (RGDX), 2012-09-21
  • Large Shareholder, Director at Human Genome Sciences Inc (HGSI), 2012-08-03
  • Large Shareholder, Director at Quest Diagnostics Inc (DGX), 2011-02-02
  • Large Shareholder at Anacor Pharmaceuticals Inc (ANAC), 2010-11-24
  • Large Shareholder at Redpoint Bio Corp (RPBC), 2010-03-16
  • Large Shareholder at Maxygen Inc (MAXY), 2010-01-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DBTX $18.00 150,000 Director 1,183,663 2021-02-17 Filing
GNCA $2.25 1,260,504 Large Shareholder 4,626,389 2020-07-24 Filing
PAND $18.00 361,111 Large Shareholder, Director 2,248,304 2020-07-21 Filing
NKTX $18.00 833,333 Large Shareholder, Director 3,150,732 2020-07-14 Filing
TPTX $60.00 83,333 Director 2,253,660 2020-05-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BCYC $19.25 78 Large Shareholder 1,910,531 2020-07-15 Filing
BCYC $19.40 3,069 Large Shareholder 1,910,609 2020-07-15 Filing
BCYC $19.27 1,597 Large Shareholder 1,913,678 2020-07-14 Filing
PGNY $25.75 4,000,000 Large Shareholder 6,238,244 2020-05-20 Filing
CCXI $11.69 7,343,492 Other 0 2018-10-16 Filing